| Name | Title | Contact Details |
|---|
Health Union integrates the power of human connection with technology to unite people in the shared experiences of life with chronic health conditions. For almost a decade, Health Union has done the hard work every day to bring people living with chronic conditions together. Through a unique and genuine approach to listening and understanding all aspects of health experiences, Health Union`s open, online communities provide a safe place for people to learn, connect and share. In doing so, social interactions evolve into meaningful health conversations. At the same time, these communities offer healthcare companies countless opportunities to understand how to reach and engage people living with these conditions in smarter, more effective ways. Today, the Health Union family of brands includes online health communities for chronic conditions in a range of categories including primary care, immunology, oncology and neurodegenerative/genetic conditions. Among them are Migraine.com, MultipleSclerosis.net, Endometriosis.net and LungCancer.net to name a few. Health Union is dedicated to making an impact on the lives of people with chronic health concerns. In 2018, that focus has been recognized. The company was named among the top 15 percent of the Inc. 5000 list of fastest-growing private companies in America and topped the list of both Philly.com`s “Top Workplaces” and Philadelphia Business Journal`s “Best Places to Work.”
Since 2007, Genalyte has been guided by the vision of taking a single drop of blood, performing panels of tests and returning accurate and reproducible results within a few minutes. We launched our first instrument in 2012 in the pharmaceutical industry and academia for a range of healthcare applications including autoimmune disease monitoring, screening of cancer biomarkers, testing for infectious agents and detecting anti-drug antibodies. By reducing tests to a microscopic size in a highly multiplex environment on the surface of silicon chips we are able to generate more information from a smaller sample in less time than conventional techniques.
NeuroSigma is a Los Angeles-based life sciences company established to develop TNS technologies with the potential to transform medical practice and patients' lives. NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property licensed on an exclusive basis from the University of California, Los Angeles (UCLA), including TNS therapies for epilepsy, depression, post-traumatic stress disorder (PTSD) and attention-deficit hyperactivity disorder (ADHD).
Alquest has supported numerous international trials and registrations for device clients. Alquest's consulting staff comes from the medical device industry. We've been there. More than half our clients return to us for repeat business. Several device
Health Access Solutions is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Foster City, CA. To find more information about Health Access Solutions, please visit www.healthaccesssolutions.com